AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2018
Dec 21, 2018
31708_dirs_2018-12-21_4f102fb7-7b50-46d0-8926-906a8d987ebb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2018-12-19
Reporting Person: Roberts David B (Director, President and Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-19 | Common Stock | A | 2653 | $0.00 | Acquired | 36362 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-19 | Stock Option (Right to Buy) | $23.56 | A | 21832 | Acquired | 2025-12-19 | Common Stock (21832) | Direct |
Footnotes
F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.